27th AMLI ANNUAL MEETING 2014

SATURDAY, AUGUST 9

7:30 

Continental Breakfast

8:30-8:35  

Opening Remarks
Susan Orton, Ph.D., AMLI President

Plenary Session 1
Transplantation
Co-Chairs: Mohamed Elrefaei, M.D., Ph.D and Julio Delgado, M.D., MS

8:35

Case Study: Non HLA Antibodies and Allograft Rejection
Mohamed Elrefaei, M.D., Ph.D.
Puget Sound Blood Center, Seattle, Washington

9:20

Post-transplant Assessment of Alloantibodies:  HLA and Beyond
Paul Warner, Ph.D.
Puget South Blood Center, Seattle, Washington

10:00

Break

10:30

Update on Diagnostic Testing for CMV in Solid Organ Transplantation
Ajit P. Limaye, M.D.
University of Washington Medical Center, Seattle, Washington

11:15

Biological Markers Post-Transplantation
Minnie Sarwal, M.D.,Ph.D.
University of California, The Sarwal Lab, San Francisco, California

12:00-1:30 pm  

Luncheon Seminar hosted by
Trinity-Immco

Plenary Session 2
Cytokines and Autoantibodies: Biomarkers and Signature Profiles in Autoimmune Diseases
Co-Chairs: Barbara Detrick, Ph.D. and Melissa R. Snyder, Ph.D.

2:00   

Case Study:  Autoimmune Disease
Matthew J. Koster, M.D.
Mayo Clinic College of Medicine, Rochester, Minnesota

2:45  

Autoantibodies and Cytokines: Mechanistic Biomarkers for Systemic Autoimmune Diseases
Jeremy Sokolove, M.D.
Stanford University School of Medicine, Palo Alto, California

3:30

Nucleic Acid Sensors and IFN- alpha Signatures in SLE
Tim Niewold, M.D.
Mayo Clinic College of Medicine, Rochester, Minnesota

4:15

Anti-Cytokine Autoantibodies –Laboratory and Clinical Issues
Sarah K. Browne, M.D.
National Institute of Allergy and Infectious Diseases, National Institutes of Health,Bethesda, Maryland

5:00-7:00

Meet the Exhibitors-Poster Session Reception

SUNDAY, AUGUST 10

Plenary Session 3
Hot Topics: Cell-based Therapies: The Basics and Practical Applications
Co-Chairs: Roshini Abraham, Ph.D. and Vijaya Knight, M.D., Ph.D.

8:30 am

Case Study: Adeno-viral Specific CTLs to Treat Refractory Adenoviremia in
a SCID Patient Post-HCT

Angela Renee Smith, M.D., MS
Pediatric Hematology-Oncology, University of Minnesota, Minneapolis

8:55 am

Requirements for a Cell-based Therapy Facility: Expecting the Unexpected
Patrick Hanley, Ph.D.
Children’s National Medical Center, The George Washington University, Washington, D.C.

9:35 am

Break

10:00 am

Practical Aspects in the Development and Implementation of Cell Therapies
Cliona Rooney, B.Sc., Ph.D.
Baylor College of Medicine and Texas Children’s Cancer and Hematology Centers, Houston, Texas

10:40 am

Adoptive regulatory T Cell (Treg) Therapy and Gene Therapy in Primary Immunodeficiencies
Troy Torgerson, M.D., Ph.D.
Seattle Children’s Research Institute, Seattle, Washington

11:20 am

T Cell Immunotherapies: Advances and Applications
Michael Keller, M.D.
Children’s National Medical Center, Washington, D. C.

12:00 noon  

Luncheon Seminar hosted by
The Binding Site
Hevylite®, a Novel Test for Monitoring Myeloma Patients/ The SPAPlus Analyzer for Special Protein Assays
Anne L. Sherwood, Ph.D., Director of Scientific Affairs, The Binding Site, Inc.
Dave Canfield, Instrument Specialist, The Binding Site, Inc.

2:00-3:00 pm    

Erwin Neter Memorial Lecture
Go with the Flow: Studying the Surface and Interior of Cells Linked to Primary Immunodeficiencies

Thomas A. Fleisher, M.D., Chief, Department of Laboratory Medicine, NIH; Chief, Immunology Service, DLM, NIH

3:00-3:30 pm

Abstract Award Presentations

4:00-6:00 pm

Meet the Exhibitors Poster Session Reception

6:15 pm

Annual Dinner – Chateau Ste. Michelle Winery
Chateau Ste. Michelle is the oldest winery in the State of Washington. We will travel the 15 miles from Seattle to Woodinville by bus. During the 45 minute cocktail period, you can also take a short tour of the vineyard or browse in the gift shop. Dinner will follow, after which the bus will return you to the hotel. Advance reservations and payment are required.

10:00

MONDAY, AUGUST 11

Plenary Session 4
Flow Cytometry – Heme Path

Co-Chairs: Antony Bakke, Ph.D. and Trivikram Dasu, Ph.D.

8:30 am

Case Study: MRD Detection Strategies
Brent Wood, M.D., Ph.D.
University of Washington, Seattle Cancer Care Alliance Laboratories, Seattle, Washington

9:15 

Use of Flow Cytometry for MDS
Sa A Wang, M.D.
MD Anderson Cancer Center, Houston, Texas

10:00 am  

Break

10:30 am  

Immunoscore
Bernard A. Fox, Ph.D.
Earle A. Chiles Research Institute, Providence Portland Medical Center,
Oregon Health and Science University, UbiVac, Portland, Oregon

11:15 am

10 Color Flow Cytometry: Leveraging Complexity to Yield Simplicity
Jeannine Holden, M.D.
Beckman Coulter, Inc., Atlanta, Georgia

12:00-1:30 pm

Luncheon Seminar hosted by Aesku
HELIOS: Taking the Human Out of the ANA Immunofluorescence Interpretation Bruce Rabin, M.D., Ph.D., University of Pittsburgh

FREE AFTERNOON

TUESDAY, AUGUST 12

Plenary Session 5
Laboratory Management
Co-Chairs: Linda Cook, Ph.D. and Evan Ntrivalas, M.D., Ph.D

8:30 am

Quality Control Design:  It’s Easier Than You Think
Curtis Parvin, Ph.D.
Bio-Rad Laboratories, Hercules, California

9:15 am

Medicare Payment Changes in 2014 and Beyond: What’s the Bottom Line?
Jonathan Myles, M.D.
Cleveland Clinic Foundation, Cleveland, Ohio

10:00 am

Break

10:30 am

CLIA and Individualized Quality Control Plan (IQCP)
Keith Scott, BS, MLS(ASCP)CM
CMS Region 10, CLIA Program, Seattle, Washington

11:15 am  

Challenges and Rewards of Creating and Using an International Laboratory Network for the HIV Clinical Trials Network (HVTN)
Constance Ducar, B.S., M.S., MT-ASCP
Fred Hutchinson Cancer Research Center, Seattle, Washington

12:00 noon

Closing Remarks